Skip to main content

Alba Mir Cros

Institutions of which they are part

Postdoctoral researcher
Microbiology
Vall Hebron Institut de Recerca

Alba Mir Cros

Institutions of which they are part

Postdoctoral researcher
Microbiology
Vall Hebron Institut de Recerca

Projects

Secuenciación d enueva generación para el estudio de la dinámica poblacional, adaptación e identificación de nuevos antígenos vacunales de B. Pertussis y B holmesii. Estudio PERT-ESP-VAC.

IP: Juan Jose Gonzalez Lopez
Collaborators: M Teresa Martin Gomez, Gema Codina Grau, Carlos Rodrigo Gonzalo de Liria, Alba Mir Cros, Sonia Maria Uriona Tuma, Sonia Maria Uriona Tuma
Funding agency: Instituto de Salud Carlos III
Funding: 111320
Reference: PI18/00703
Duration: 01/01/2019 - 30/06/2023

Inhibició dels sistemes d¿estabilitat plasmídics com a eina de lluita front a bacteris multirresistents

IP: Juan Jose Gonzalez Lopez
Collaborators: Alba Mir Cros, Laia Perez Lasarte
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 46200
Reference: 2018 FI_B 00855
Duration: 01/03/2018 - 31/03/2021

Incorporació Dr. Benito Almirante a la RETICS en malalties infeccioses RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS

IP: -
Collaborators: María Nieves Larrosa Escartin, Oscar Len Abad, Gema Codina Grau, Mª Carmen Ferrer Barberà, Andres Antón Pagarolas, Rosa María Bartolomé Comas, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juliana Esperalba Esquerra, Ma Dolores Rodríguez Pardo, Alba Mir Cros, Julia Sellares Nadal, Tomàs Pumarola Suñé, Carles Pigrau Serrallach, Isabel Ruiz Camps, Mayli Lung Suarez, Mª Teresa Tórtola Fernández, Juan Jose Gonzalez Lopez, Pablo Salvador Corona Pérez-Cardona, Ibai Los Arcos Bertiz
Funding agency: Instituto de Salud Carlos III
Funding: 401918
Reference: RD16/0016/0003
Duration: 01/01/2017 - 31/12/2022

Related news

The initiative focuses on awareness, prevention, and the normalization of sexual health check-ups among young people.

All patients showed a favorable clinical course and responded well to antibiotic treatment, without complications.

The study results show that the local presence of IL-1β promotes the development of myeloid cells with an immunosuppressive function.

Related professionals

Carlos  De la fuente  Vazquez

Carlos De la fuente Vazquez

New Technologies and Craniofacial Microsurgery
Read more
Jordi Navarro Mercadé

Jordi Navarro Mercadé

Main researcher
Infectious Diseases
Read more
Raquel Cabrera Perez

Raquel Cabrera Perez

Senior researcher
Musculoskeletal Tissue Engineering
Read more
Joaquin Burgos Cibrian

Joaquin Burgos Cibrian

Main researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.